Patents by Inventor Ryan Huddleston

Ryan Huddleston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6743941
    Abstract: The present invention relates to processes for preparing certain piperidine derivatives, including fexofenadine (F), the active ingredient in the non-sedating antihistamine sold in the U.S. under the designation “Allegra®”. This invention also relates to novel synthetic intermediates useful in the processes of the present invention.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: June 1, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Collin Schroeder, Ryan Huddleston, Richard Charles
  • Publication number: 20030105329
    Abstract: The present invention relates to processes for preparing certain piperidine derivatives, including fexofenadine (F), the active ingredient in the non-sedating antihistamine sold in the U.S. under the designation “Allegra®”. This invention also relates to novel synthetic intermediates useful in the processes of the present invention.
    Type: Application
    Filed: June 11, 2002
    Publication date: June 5, 2003
    Inventors: Collin Schroeder, Ryan Huddleston, Richard Charles